Condition (MeSH)
Encephalomyelitis, Eastern Equine
ClinicalTrials.gov lists 3 trials for Encephalomyelitis, Eastern Equine or a narrower condition beneath it. U.S. Army Medical Research and Development Command has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Encephalomyelitis, Eastern Equine itself; the rest are tagged with a narrower condition beneath it.
When did Encephalomyelitis, Eastern Equine trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2019 | 1 |
| 2008 | 2 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Encephalomyelitis, Eastern Equine trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
How many Encephalomyelitis, Eastern Equine trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Encephalomyelitis, Eastern Equine trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| U.S. Army Medical Research and Development Command | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Which serious adverse events do Encephalomyelitis, Eastern Equine trials report? (7)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Atrial febrillation | 1 | 1 |
| Biscuspid aortic valve | 1 | 1 |
| Colon cancer | 1 | 1 |
| Coronary artery disease | 1 | 1 |
| Infectious mononucleosis | 1 | 1 |
Showing 5 of 7 adverse events.
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Eastern equine encephalitis | Annual incidence | <1 / 1 000 000 | United States | US | Unspecified |
| Eastern equine encephalitis | Annual incidence | <1 / 1 000 000 | United States | US | Exact |
| Eastern equine encephalitis | Annual incidence | <1 / 1 000 000 | United States | US | Exact |
| Eastern equine encephalitis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Eastern equine encephalitis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Eastern equine encephalitis | 83594 | Exact | Orphadata Science knowledge files, Product 1 |
| Eastern equine encephalitis | 83594 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: publications and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.